Tuesday, June 14, 2011
HUNTINGTON, W.Va. – Marshall University today announced it will be partnering with the University of Kentucky (UK) as part of the National Institutes of Health (NIH) institutional Clinical and Translational Science Awards (CTSA) program aimed at speeding the time for laboratory discoveries to benefit patients.
NIH has awarded $20 million to support research at UK’s Center for Clinical and Translational Science (CCTS), making it part of a select national biomedical research network. Marshall will be awarded a subcontract of up to $750,000 over the course of the five-year grant.
The funding will support scientists in Marshall’s clinical research program, training fellowships and early stage clinical research trials. The partnership also will give Marshall access to the expertise and resources at UK’s CCTS, and opportunities to apply for significant research grants accessible only through the CTSA program.
“Marshall University is proud to be partnering with the University of Kentucky on this national grant award,” said Marshall President Stephen J. Kopp. “Our participation in this multi-state award ensures that the state of West Virginia will be represented in this national consortium of medical research institutions. We share the commitment of all CTSA members to work together to achieve the transformative strategic goals of this innovative program and look forward to realizing the full potential of its promise, especially on behalf of the people of Appalachia.”
According to Dr. John M. Maher, vice president for research at Marshall, investigators in the national CTSA network are already working together to advance medical research on many of the diseases and conditions that disproportionately affect those who live in the region.
He said that researchers at Marshall’s Joan C. Edwards School of Medicine and the Marshall Institute for Interdisciplinary Research will be involved in the project, and that the areas targeted for clinical research collaboration with UK include cancer, cardiovascular disease and diabetes.
“CTSA funding of Marshall’s partnership with the University of Kentucky will accelerate our efforts in clinical and translational research, and forge new collaborations to solve some of the most pervasive health problems in Appalachia,” added Maher.
Dr. Philip Kern, associate provost for clinical and translational science at UK, said, “Marshall has substantial clinical expertise and basic science research strength in these areas and we welcome the opportunity to partner with them to enhance both of our biomedical research programs.”
Dr. Charles H. McKown Jr., dean of Marshall’s Joan C. Edwards School of Medicine, said the populations served by Marshall’s Robert C. Byrd Center for Rural Health and the UK Centers for Rural Health, which border each other geographically, provide the opportunity to enhance translational research and participation in clinical trials throughout the Appalachian region.
McKown added, “This award is significant because not only will our researchers be able to tap into the national CTSA resources to help speed the translation of scientific discoveries into treatments for patients, we will also be able to more fully engage our rural communities in clinical research efforts and better train a whole new generation of researchers.”
NIH launched the CTSA program in 2006 to encourage collaboration across scientific disciplines and spur innovative approaches in tackling research challenges. With the addition of the 2011 recipient institutions announced today, the program is fully implemented and includes 60 CTSAs across the nation.
For more information about the CTSA program, visit http://www.ncats.nih.gov/research/cts/ctsa/ctsa.html. The CTSA consortium website, which provides information about the consortium, current members and new grantees, can be accessed at https://ctsacentral.org. For more information about the UK CCTS and its partners, visit www.ccts.uky.edu.
“I congratulate Marshall University on receiving this prestigious grant. The CTSA is a significant step forward for our state because now we can combine expert research from across the country with Marshall’s strong focus and experience in rural medicine. This also means that we will have access to future NIH funding and resources that will lead to better health care initiatives for people in West Virginia, and other rural and underserved areas of the country.”
—U.S. Senator Jay Rockefeller
“Today’s announcement is not only a wonderful opportunity for Marshall University, but also for our entire state. This partnership fosters future progress in health studies and incorporates Appalachian rural communities into critical medical research. I applaud Marshall’s staff, faculty and students for their participation in this important partnership, because I am confident that all West Virginians will benefit from this collaborative effort.”
—U.S. Senator Joe Manchin
“Marshall has opened an important and sizable door of opportunity to meet rural health needs and to address chronic diseases all too prevalent in Appalachia. Marshall medicine was born out of a federal investment; by supporting these initiatives and helping Marshall to unite its valuable resources and insight with researchers elsewhere, we help shape the course of future clinical research in the nation.”
—U.S. Rep. Nick Rahall
“Marshall University has forged a path as a leader in the biomedical field. This collaboration with the University of Kentucky further solidifies Marshall’s position while offering great promise for improved health care in our state and region. I look forward to the new discoveries that will emerge from this opportunity.”
—Governor Earl Ray Tomblin
Ginny Painter, Communications Director, Marshall University Research Corporation, 304.746.1964
Kristi Lopez, Director, Medical Center Public Relations, University of Kentucky, 859.323.6363 x. 224
Herald-Dispatch: MU to help speed up innovations in health (June 15, 2011)
University of Kentucky CTSA news release (June 14, 2011)